Arcellx Inc (ACLX)

Arcellx Inc (ACLX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of May 15, 2026: market cap $6.7B; returns 1 week +0.0%, 1 year +96.9%.

Arcellx, Inc. is a clinical-stage biotechnology company focused on developing innovative immunotherapies for cancer and other incurable diseases. The company's core technology revolves around its proprietary D-Domain platform, which utilizes novel synthetic binding domains to create advanced Chimeric Antigen Receptor T-cell (CAR-T) therapies.

ACLX financial model: income statement, cash flow and balance sheet